Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)
07 Juillet 2022 - 10:19PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14D-9
SOLICITATION/RECOMMENDATION STATEMENT
PURSUANT TO SECTION 14(d)(4) OF THE SECURITIES EXCHANGE ACT OF 1934
RADIUS HEALTH, INC.
(Name of Subject Company)
RADIUS
HEALTH, INC.
(Name of Person(s) Filing Statement)
Common Stock, $0.0001 par value per share
(Title of Class of Securities)
750469207
(CUSIP Number
of Common Stock)
G. Kelly Martin
President and Chief Executive Officer
Radius Health, Inc.
22
Boston Wharf Road, 7th Floor
Boston, Massachusetts 02210
(617) 551-4000
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications on Behalf of the Person(s) Filing Statement)
With a copy to:
|
Zachary Blume
Marc Rubenstein
Ropes & Gray LLP
Prudential Tower 800
Boylston Street Boston, Massachusetts 02199
(617) 951-7000 |
☒ |
Check the box if the filing relates solely to preliminary communications made before the commencement of a
tender offer. |
This Schedule 14D-9C consists of the following documents related to
the proposed acquisition of Radius Health, Inc., a Delaware corporation (the Company), pursuant to an Agreement and Plan of Merger, dated as of June 23, 2022, by and among the Company, Ginger Acquisition, Inc., a Delaware
corporation (Parent), a subsidiary jointly owned by Gurnet Point Capital, LLC and Patient Square Capital and Ginger Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent.
1. Investor Presentation, dated as of July 7, 2022.
Item
#1 above was first used or made available on July 7, 2022.
Radius Recycling (NASDAQ:RDUS)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Radius Recycling (NASDAQ:RDUS)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024